{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["COVID-19", "SARS-CoV-2 epidemiology", "deaths rate", "healthcare system", "paracetamol"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "35409942", "DateCompleted": {"Year": "2022", "Month": "04", "Day": "13"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "04", "Day": "02"}], "ELocationID": ["4262", "10.3390/ijerph19074262"], "Journal": {"ISSN": "1660-4601", "JournalIssue": {"Volume": "19", "Issue": "7", "PubDate": {"Year": "2022", "Month": "Apr", "Day": "02"}}, "Title": "International journal of environmental research and public health", "ISOAbbreviation": "Int J Environ Res Public Health"}, "ArticleTitle": "COVID-19 Medical and Pharmacological Management in the European Countries Compared to Italy: An Overview.", "Abstract": {"AbstractText": ["(1) Background: Italy accounts for more than 150,000 deaths due to the COVID-19 pandemic, leading the top rank in SARS-CoV-2-caused deceases in Europe. A survey on the different ways by which the COVID-19 pandemic emergency was managed in the foreign European countries compared to Italy is the purpose of this paper. (2) Methods: A literature search and various mathematical algorithms to approach a rank scoring scale were used to describe in detail the different approaches used by European countries to manage the COVID-19 pandemic emergency. (3) Results: The study showed that Italy stands at the bottom ranking for COVID-19 management due to its high mortality rate. Possible causes of the observed huge numbers of hospitalization and deaths were (a) the demographic composition of the European country; (b) its decentralized healthcare system organization; (c) the role of correct pharmacology in the early stages before hospitalization. Post-mortem examinations were of paramount importance to elucidate the etiopathogenesis of COVID-19 and to tailor a suitable and proper therapy in the early symptomatic stages of COVID-19, preventing hospitalization. (4) Conclusions: Factors such as the significant impact on elderly people, the public health organization prevalently state-owned and represented mainly by hospitals, and criticism of the home therapy approach toward SARS-CoV-2-infected people, may have concurred in increasing the number of COVID-19 deaths in Italy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "High School Master of Oxygen-Ozone Therapy, University of Pavia, 27100 Pavia, Italy."}], "LastName": "Pandolfi", "ForeName": "Sergio", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "High School Master of Oxygen-Ozone Therapy, University of Pavia, 27100 Pavia, Italy."}], "LastName": "Valdenassi", "ForeName": "Luigi", "Initials": "L"}, {"Identifier": ["0000-0003-2632-3935"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Council for Nutritional and Environmental Medicine (CONEM), 8610 Mo i Rana, Norway."}], "LastName": "Bj\u00f8rklund", "ForeName": "Geir", "Initials": "G"}, {"Identifier": ["0000-0003-1789-8307"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Council for Nutritional and Environmental Medicine (CONEM), 8610 Mo i Rana, Norway."}], "LastName": "Chirumbolo", "ForeName": "Salvatore", "Initials": "S"}, {"Identifier": ["0000-0003-0961-2970"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy and Botany, Danylo Halytsky Lviv National Medical University, 79010 Lviv, Ukraine."}], "LastName": "Lysiuk", "ForeName": "Roman", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Standardization Kharkiv, National University of Pharmacy, 61002 Kharkiv, Ukraine."}], "LastName": "Lenchyk", "ForeName": "Larysa", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Ovidius University, 900527 Constan\u021ba, Romania."}], "LastName": "Do\u015fa", "ForeName": "Monica Daniela", "Initials": "MD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Internal Medicine, University of Naples Federico II, 80138 Naples, Italy."}], "LastName": "Fazio", "ForeName": "Serafino", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Environ Res Public Health", "NlmUniqueID": "101238455", "ISSNLinking": "1660-4601"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": ["epidemiology"], "DescriptorName": "COVID-19"}, {"QualifierName": ["epidemiology"], "DescriptorName": "Europe"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["epidemiology"], "DescriptorName": "Italy"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "COVID-19 Excess Mortality Collaborators Estimating excess mortality due to the COVID-19 pandemic: A systematic analysis of COVID-19-related mortality, 2020-21. Lancet. 2022;10 doi: 10.1016/S0140-6736(21)02796-3.", "ArticleIdList": ["10.1016/S0140-6736(21)02796-3", "PMC8912932", "35279232"]}, {"Citation": "Tyrovolas S., Tsiampalis T., Morena M., Leung A.Y.M., Faka A., Chalkias C., Tsiodras S., Panagiotakos D. COVID-19 Mortality in Europe, by Latitude and Obesity Status: A Geo-Spatial Analysis in 40 Countries. Nutrients. 2022;14:471. doi: 10.3390/nu14030471.", "ArticleIdList": ["10.3390/nu14030471", "PMC8839557", "35276831"]}, {"Citation": "Alfieri C., Egrot M., Desclaux A., Sams K. CoMeSCov. Recognising Italy\u2019s mistakes in the public health response to COVID-19. Lancet. 2022;399:357\u2013358. doi: 10.1016/S0140-6736(21)02805-1.", "ArticleIdList": ["10.1016/S0140-6736(21)02805-1", "PMC8776317", "35065781"]}, {"Citation": "Dorrucci M., Minelli G., Boros S., Manno V., Prati S., Battaglini M., Corsetti G., Andrianou X., Riccardo F., Fabiani M., et al. Excess Mortality in Italy During the COVID-19 Pandemic: Assessing the Differences Between the First and the Second Wave, Year 2020. Front. Public Health. 2021;9:669209. doi: 10.3389/fpubh.2021.669209.", "ArticleIdList": ["10.3389/fpubh.2021.669209", "PMC8322580", "34336767"]}, {"Citation": "Levi M., Cipriani F., Romeo G., Balzi D. Analysis of the excess mortality and factors associated with deaths from COVID-19 versus other causes in Central Tuscany (Italy) in 2020. Epidemiol. Prev. 2021;45:496\u2013503.", "ArticleIdList": ["35001596"]}, {"Citation": "Odone A., Delmonte D., Gaetti G., Signorelli C. Doubled mortality rate during the COVID-19 pandemic in Italy: Quantifying what is not captured by surveillance. Public Health. 2021;190:108\u2013115. doi: 10.1016/j.puhe.2020.11.016.", "ArticleIdList": ["10.1016/j.puhe.2020.11.016", "PMC7703200", "33412438"]}, {"Citation": "Blangiardo M., Cameletti M., Pirani M., Corsetti G., Battaglini M., Baio G. Estimating weekly excess mortality at sub-national level in Italy during the COVID-19 pandemic. PLoS ONE. 2020;15:e0240286. doi: 10.1371/journal.pone.0240286.", "ArticleIdList": ["10.1371/journal.pone.0240286", "PMC7546500", "33035253"]}, {"Citation": "Sandrini M., Andreano A., Murtas R., Tunesi S., Riussi A., Guido D., Greco M.T., Gattoni M.E., Gervasi F., Consolazio D., et al. Assessment of the Overall Mortality during the COVID-19 Outbreak in the Provinces of Milan and Lodi (Lombardy Region, Northern Italy) Epidemiol. Prev. 2020;44:244\u2013251.", "ArticleIdList": ["33412816"]}, {"Citation": "Amore S., Puppo E., Melara J., Terracciano E., Gentili S., Liotta G. Impact of COVID-19 on older adults and role of long-term care facilities during early stages of epidemic in Italy. Sci. Rep. 2021;11:12530. doi: 10.1038/s41598-021-91992-9.", "ArticleIdList": ["10.1038/s41598-021-91992-9", "PMC8206111", "34131216"]}, {"Citation": "de Leo D., Trabucchi M. COVID-19 and the Fears of Italian Senior Citizens. Int. J. Environ. Res. Public Health. 2020;17:3572. doi: 10.3390/ijerph17103572.", "ArticleIdList": ["10.3390/ijerph17103572", "PMC7277474", "32443683"]}, {"Citation": "Pandolfi S., Simonetti V., Ricevuti G., Chirumbolo S. Paracetamol in the home treatment of early COVID-19 symptoms: A possible foe rather than a friend for elderly patients? J. Med. Virol. 2021;93:5704\u20135706. doi: 10.1002/jmv.27158. Erratum in J. Med. Virol. 2022, Epub ahead of print.", "ArticleIdList": ["10.1002/jmv.27158", "PMC8426871", "34170556"]}, {"Citation": "Pandolfi S., Chirumbolo S., Ricevuti G., Valdenassi L., Bj\u00f8rklund G., Lysiuk R., Do\u015fa M.D., Lenchyk L., Fazio S. Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal. Basic Clin. Pharmacol. Toxicol. 2021;130:225\u2013239. doi: 10.1111/bcpt.13690.", "ArticleIdList": ["10.1111/bcpt.13690", "PMC9011697", "34811895"]}, {"Citation": "Suter F., Consolaro E., Pedroni S., Moroni C., Past\u00f2 E., Paganini M.V., Pravettoni G., Cantarelli U., Rubis N., Perico N., et al. A simple, home-therapy algorithm to prevent hospitalisation for COVID-19 patients: A retrospective observational matched-cohort study. EClinicalMedicine. 2021;37:100941. doi: 10.1016/j.eclinm.2021.100941.", "ArticleIdList": ["10.1016/j.eclinm.2021.100941", "PMC8189543", "34127959"]}, {"Citation": "Consolaro E., Suter F., Rubis N., Nurse R., Pedroni S., Moroni C., Past\u00f2 E., Paganini M.V., Pravettoni G., Cantarelli U., et al. A home-treatment algorithmbased on anti-inflammatory drugs to prevcent hospitalization of patients with early COVID-19. A matched-cohort study (COVER 2) MedRXiv. 2021 doi: 10.1101/2021.09.29.21264298.", "ArticleIdList": ["10.1101/2021.09.29.21264298", "PMC8189543", "34127959"]}, {"Citation": "Sestili P., Fimognari C. Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness? Front. Pharmacol. 2020;11:579944. doi: 10.3389/fphar.2020.579944.", "ArticleIdList": ["10.3389/fphar.2020.579944", "PMC7577213", "33117175"]}, {"Citation": "Larsen J.R., Martin M.R., Martin J.D., Kuhn P., Hicks J.B. Modeling the Onset of Symptoms of COVID-19. Front. Public Health. 2020;8:473. doi: 10.3389/fpubh.2020.00473.", "ArticleIdList": ["10.3389/fpubh.2020.00473", "PMC7438535", "32903584"]}, {"Citation": "Casey D., Geulayov G., Bale E., Brand F., Clements C., Kapur N., Ness J., Patel A., Waters K., Hawton K. Paracetamol self-poisoning: Epidemiological study of trends and patient characteristics from the multicentre study of self-harm in England. J. Affect. Disord. 2020;276:699\u2013706. doi: 10.1016/j.jad.2020.07.091.", "ArticleIdList": ["10.1016/j.jad.2020.07.091", "32871703"]}, {"Citation": "Hawton K., Bergen H., Simkin S., Arensman E., Corcoran P., Cooper J., Waters K., Gunnell D., Kapur N. Impact of different pack sizes of paracetamol in the United Kingdom and Ireland on intentional overdoses: A comparative study. BMC Public Health. 2011;11:460. doi: 10.1186/1471-2458-11-460.", "ArticleIdList": ["10.1186/1471-2458-11-460", "PMC3125378", "21663604"]}, {"Citation": "Simkin S., Hawton K., Kapur N., Gunnell D. What can be done to reduce mortality from paracetamol overdoses? A patient interview study. QJM. 2012;105:41\u201351. doi: 10.1093/qjmed/hcr135.", "ArticleIdList": ["10.1093/qjmed/hcr135", "21856743"]}, {"Citation": "Morthorst B.R., Erlangsen A., Nordentoft M., Hawton K., Hoegberg L.C.G., Dalhoff K.P. Availability of Paracetamol Sold Over the Counter in Europe: A Descriptive Cross-Sectional International Survey of Pack Size Restriction. Basic Clin. Pharm. Toxicol. 2018;122:643\u2013649. doi: 10.1111/bcpt.12959.", "ArticleIdList": ["10.1111/bcpt.12959", "29319222"]}, {"Citation": "Schneider A., Kirsten H., Lordick F., Lordick F., L\u00fcbbert C., von Braun A. COVID-19 in outpatients-Is fever a useful indicator for SARS-CoV-2 infection? PLoS ONE. 2021;16:e0246312.", "ArticleIdList": ["PMC7857607", "33534829"]}, {"Citation": "Ws Chew N., Nicholas Ngiam J., Meng Tham S., Yu Lim Z., Yi-Wei Li T., Cen S., Soo Yap E., Anantharajah T.P., Santosa A., Brenda Cross G., et al. Fever as a predictor of adverse outcomes in COVID-19. QJM. 2021;20:1043\u20131050.", "ArticleIdList": ["PMC7928573", "33533902"]}, {"Citation": "Romano S., Galante H., Figueira D., Mendes Z., Rodrigues A.T. Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: Data from community pharmacies. Res. Soc. Adm. Pharm. 2021;17:1876\u20131881. doi: 10.1016/j.sapharm.2020.05.024.", "ArticleIdList": ["10.1016/j.sapharm.2020.05.024", "PMC7245321", "32482587"]}, {"Citation": "Fang L., Karakiulakis G., Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir. Med. 2020;8:e21. doi: 10.1016/S2213-2600(20)30116-8.", "ArticleIdList": ["10.1016/S2213-2600(20)30116-8", "PMC7118626", "32171062"]}, {"Citation": "Day M. COVID-19: Ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ. 2020;368:m1086. doi: 10.1136/bmj.m1086.", "ArticleIdList": ["10.1136/bmj.m1086", "32184201"]}, {"Citation": "Kazama I., Senzaki M. Does immunosuppressive property of non-steroidal anti-inflammatory drugs (NSAIDs) reduce COVID-19 vaccine-induced systemic side effects? Drug Discov. Ther. 2021;15:278\u2013280. doi: 10.5582/ddt.2021.01094.", "ArticleIdList": ["10.5582/ddt.2021.01094", "34707073"]}, {"Citation": "Drake T.M., Fairfield C.J., Pius R., Knight S.R., Norman L., Girvan M., Hardwick H.E., Docherty A.B., Thwaites R.S., Openshaw P.J.M., et al. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: A matched, prospective cohort study. Lancet Rheumatol. 2021;3:e498\u2013e506. doi: 10.1016/S2665-9913(21)00104-1.", "ArticleIdList": ["10.1016/S2665-9913(21)00104-1", "PMC8104907", "33997800"]}, {"Citation": "Onuora S. NSAIDs not linked to worse COVID-19 outcomes. Nat. Rev. Rheumatol. 2021;17:378. doi: 10.1038/s41584-021-00645-8.", "ArticleIdList": ["10.1038/s41584-021-00645-8", "PMC8168292", "34075239"]}, {"Citation": "Lund L.C., Kristensen K.B., Reilev M., Christensen S., Thomsen R.W., Christiansen C.F., St\u00f8vring H., Johansen N.B., Brun N.C., Hallas J., et al. Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study. PLoS Med. 2020;17:e1003308. doi: 10.1371/journal.pmed.1003308.", "ArticleIdList": ["10.1371/journal.pmed.1003308", "PMC7478808", "32898149"]}, {"Citation": "Estella \u00c1., Garnacho-Montero J. Del empirismo a la evidencia cient\u00edfica en el tratamiento con antiv\u00edricos en los casos graves de infecci\u00f3n por coronavirus en tiempos de epidemia [From empiricism to scientific evidence in antiviral treatment in severe cases of coronavirus infection in times of epidemic] Med. Intensiva. 2020;44:509\u2013512.", "ArticleIdList": ["PMC7174180", "32423569"]}, {"Citation": "Kupferschmidt K., Cohen J. Race to find COVID-19 treatments accelerates. Science. 2020;367:1412\u20131413. doi: 10.1126/science.367.6485.1412.", "ArticleIdList": ["10.1126/science.367.6485.1412", "32217705"]}, {"Citation": "Marto N., Monteiro E.C. Medicines for the Treatment Of COVID-19: Awaiting the Evidence. Acta Med. Port. 2020;33:500\u2013504. doi: 10.20344/amp.13908.", "ArticleIdList": ["10.20344/amp.13908", "32425152"]}, {"Citation": "Fortaleza C.M.C.B. Evidence, rationality, and ignorance: Agnotological issues in COVID-19 science. Rev. Soc. Bras. Med. Trop. 2020;53:e20200475. doi: 10.1590/0037-8682-0475-2020.", "ArticleIdList": ["10.1590/0037-8682-0475-2020", "PMC7508199", "32965456"]}, {"Citation": "Sanders J.M., Monogue M.L., Jodlowski T.Z., Cutrell J.B. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;323:1824\u20131836. doi: 10.1001/jama.2020.6019.", "ArticleIdList": ["10.1001/jama.2020.6019", "32282022"]}, {"Citation": "Bonaventura A., Vecchi\u00e9 A., Dagna L., Martinod K., Dixon D.L., Van Tassell B.W., Dentali F., Montecucco F., Massberg S., Levi M., et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat. Rev. Immunol. 2021;21:319\u2013329. doi: 10.1038/s41577-021-00536-9.", "ArticleIdList": ["10.1038/s41577-021-00536-9", "PMC8023349", "33824483"]}, {"Citation": "Parthasarathy U., Martinelli R., Vollmann E.H., Best K., Therien A.G. The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders. Biochem. Pharmacol. 2021;195:114847. doi: 10.1016/j.bcp.2021.114847.", "ArticleIdList": ["10.1016/j.bcp.2021.114847", "PMC8600760", "34801526"]}, {"Citation": "Romay-Barja M., Pascual-Carrasco M., De Tena-D\u00e1vila M.J., Falc\u00f3n M., Rodriguez-Blazquez C., Forjaz M.J., Ayala A., Molina-de la Fuente I., Burgos A., Mu\u00f1oz A., et al. How patients with COVID-19 managed the disease at home during the first wave in Spain: A cross-sectional study. BMJ Open. 2021;11:e048702. doi: 10.1136/bmjopen-2021-048702.", "ArticleIdList": ["10.1136/bmjopen-2021-048702", "PMC8137165", "34016666"]}, {"Citation": "Galluccio F., Ergonenc T., Garcia Martos A., Allam A.E., P\u00e9rez-Herrero M., Aguilar R., Emmi G., Spinicci M., Terrancle Juan I., Fajardo-P\u00e9rez M. Treatment algorithm for COVID-19: A multidisciplinary point of view. Clin. Rheumatol. 2020;39:2077\u20132084. doi: 10.1007/s10067-020-05179-0.", "ArticleIdList": ["10.1007/s10067-020-05179-0", "PMC7255973", "32472459"]}, {"Citation": "Pandolfi S., Chirumbolo S. Home therapy of COVID-19 at the earliest may greatly prevent hospitalization. Basic Clin. Pharmacol. Toxicol. 2021;129:395\u2013396. doi: 10.1111/bcpt.13650.", "ArticleIdList": ["10.1111/bcpt.13650", "PMC8652880", "34494369"]}, {"Citation": "Vetrugno G., Laurenti P., Franceschi F., Foti F., D\u2019Ambrosio F., Cicconi M., LAMilia D.I., Di Pumpo M., Carini E., Pascucci D., et al. Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): Preliminary results from a retrospective cohort study. Eur. Rev. Med. Pharmacol. Sci. 2021;25:2785\u20132794.", "ArticleIdList": ["33829463"]}, {"Citation": "Mauro V., Lorenzo M., Paolo C., Sergio H. Treat all COVID 19-positive patients, but do not forget those negative with chronic diseases. Intern. Emerg. Med. 2020;15:787\u2013790. doi: 10.1007/s11739-020-02395-z. Erratum in Intern. Emerg. Med. 2021, 16, 249.", "ArticleIdList": ["10.1007/s11739-020-02395-z", "PMC7282471", "32519136"]}, {"Citation": "Zach H., Hanov\u00e1 M., Letkovi\u010dov\u00e1 M. Distribution of COVID-19 cases and deaths in Europe during the first 12 peak weeks of outbreak. Cent. Eur. J. Public Health. 2021;29:9\u201313. doi: 10.21101/cejph.a6394.", "ArticleIdList": ["10.21101/cejph.a6394", "33831280"]}, {"Citation": "Madan M., Mohan A., Madan K., Hadda V., Tiwari P., Guleria R., Mittal S. Timing of Anti-viral therapy in COVID-19: Key to success. Adv. Respir. Med. 2021;89:237\u2013239. doi: 10.5603/ARM.a2021.0020.", "ArticleIdList": ["10.5603/ARM.a2021.0020", "33871042"]}, {"Citation": "Sundararaj Stanleyraj J., Sethuraman N., Gupta R., Thiruvoth S., Gupta M., Ryo A. Treating COVID-19: Are we missing out the window of opportunity? J. Antimicrob. Chemother. 2021;76:283\u2013285. doi: 10.1093/jac/dkaa442.", "ArticleIdList": ["10.1093/jac/dkaa442", "PMC7665528", "33099620"]}, {"Citation": "Fazio S., Bellavite P., Zanolin E., McCullough P.A., Pandolfi S., Affuso F. Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis of Early COVID-19 and Treated at Home Within 3 Days or After 3 Days of Symptom Onset with Prescribed and Non-Prescribed Treatments Between November 2020 and August 2021. Med. Sci. Monit. 2021;28:935379. doi: 10.12659/msm.935379.", "ArticleIdList": ["10.12659/msm.935379", "PMC8725339", "34966165"]}, {"Citation": "Feuillet V., Canard B., Trautmann A. Combining Antivirals and Immunomodulators to Fight COVID-19. Trends Immunol. 2021;42:31\u201344. doi: 10.1016/j.it.2020.11.003.", "ArticleIdList": ["10.1016/j.it.2020.11.003", "PMC7664349", "33281063"]}, {"Citation": "de Girolamo L., Peretti G.M., Maffulli N., Brini A.T. COVID-19-The real role of NSAIDs in Italy. J. Orthop. Surg. Res. 2020;15:165. doi: 10.1186/s13018-020-01682-x.", "ArticleIdList": ["10.1186/s13018-020-01682-x", "PMC7197233", "32366317"]}, {"Citation": "AIFA . National Report on Medicines use in Italy. Year 2019. Italian Medicines Agency; Rome, Italy: 2020. The Medicines Utilisation Monitoring Centre; p. 576."}, {"Citation": "Laurent S., Agabiti-Rosei C., Bruno R.M., Rizzoni D. Microcirculation and Macrocirculation in Hypertension: A Dangerous Cross-Link? Hypertension. 2022;79:479\u2013490. doi: 10.1161/HYPERTENSIONAHA.121.17962.", "ArticleIdList": ["10.1161/HYPERTENSIONAHA.121.17962", "34984924"]}, {"Citation": "Strain W.D., Pald\u00e1nius P.M. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc. Diabetol. 2018;17:57. doi: 10.1186/s12933-018-0703-2. Erratum in Cardiovasc. Diabetol. 2021, 20, 120.", "ArticleIdList": ["10.1186/s12933-018-0703-2", "PMC5905152", "29669543"]}, {"Citation": "Lopez-Villegas A., Bautista-Mesa R.J., Baena-Lopez M.A., Garzon-Miralles A., Castellano-Ortega M.A., Leal-Costa C., Peiro S. Impact of the COVID-19 Pandemic on Healthcare Activity in the Regional Hospitals of Andalusia (Spain) J. Clin. Med. 2022;11:363. doi: 10.3390/jcm11020363.", "ArticleIdList": ["10.3390/jcm11020363", "PMC8781610", "35054055"]}, {"Citation": "Elke B., Juliane W., Helene E., Ulrike N., Dimitra P., Christoph R., Tanja R., Reinhard B. A country-level analysis comparing hospital capacity and utilisation during the first COVID-19 wave across Europe. Health Policy. 2021;S0168-8510(21)00290-6:9.", "ArticleIdList": ["PMC8632742", "34924210"]}, {"Citation": "Ballesteros Sanz M.\u00c1., Hern\u00e1ndez-Tejedor A., Estella \u00c1., Jim\u00e9nez Rivera J.J., Gonz\u00e1lez de Molina Ortiz F.J., Sandiumenge Camps A., de Haro C., Aguilar Alonso E., Bordej\u00e9 Laguna L., Gonz\u00e1lez de Molina Ortiz F.J., et al. Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients in the coronavirus disease (COVID-19) Med. Intensiva. 2020;44:371\u2013388. doi: 10.1016/j.medin.2020.04.001.", "ArticleIdList": ["10.1016/j.medin.2020.04.001", "PMC7142677", "32360034"]}, {"Citation": "P\u00e9rez-Belmonte L.M., L\u00f3pez-Carmona M.D., Quevedo-Mar\u00edn J.L., Ricci M., Mart\u00edn-Carmona J., Sanz-C\u00e1novas J., L\u00f3pez-Sampalo A., Mart\u00edn-Escalante M.D., Bernal-L\u00f3pez M.R., G\u00f3mez-Huelgas R. Differences between Clinical Protocols for the Treatment of Coronavirus Disease 2019 (COVID-19) in Andalusia, Spain. Int. J. Environ. Res. Public Health. 2020;17:6845. doi: 10.3390/ijerph17186845.", "ArticleIdList": ["10.3390/ijerph17186845", "PMC7558914", "32961675"]}, {"Citation": "Mitj\u00e0 O., Corbacho-Monn\u00e9 M., Ubals M., Teb\u00e9 C., Pe\u00f1afiel J., Tobias A., Ballana E., Alemany A., Riera-Mart\u00ed N., P\u00e9rez C.A., et al. Hydroxychloroquine for Early Treatment of Adults With Mild Coronavirus Disease 2019: A Randomized, Controlled Trial. Clin. Infect. Dis. 2021;73:e4073\u2013e4081. doi: 10.1093/cid/ciaa1009.", "ArticleIdList": ["10.1093/cid/ciaa1009", "PMC7454406", "32674126"]}, {"Citation": "Rodr\u00edguez M. El sector p\u00fablico y el sector privado de la sanidad: \u00bfestabilidad o cambio? [The public and the private healthcare sector in Spain: Stability or change?] Gac. Sanit. 2019;33:499\u2013501. doi: 10.1016/j.gaceta.2019.08.001.", "ArticleIdList": ["10.1016/j.gaceta.2019.08.001", "31585771"]}, {"Citation": "Ferre F., de Belvis A.G., Valerio L., Longhi S., Lazzari A., Fattore G., Ricciardi W., Maresso A. Italy: Health system review. Health Syst. Transit. 2014;16:1\u2013168.", "ArticleIdList": ["25471543"]}, {"Citation": "de Almeida Simoes J., Augusto G.F., Fronteira I., Hernandez-Quevedo C. Portugal: Health System Review. Health Syst. Transit. 2017;19:1\u2013184.", "ArticleIdList": ["28485714"]}, {"Citation": "Sirven N., Rapp T. The Dynamics of Hospital Use among Older People Evidence for Europe Using SHARE Data. Health Serv. Res. 2017;52:1168\u20131184. doi: 10.1111/1475-6773.12518.", "ArticleIdList": ["10.1111/1475-6773.12518", "PMC5441513", "27319798"]}, {"Citation": "Pifarr\u00e9 IArolas H., Acosta E., L\u00f3pez-Casasnovas G., Lo A., Nicodemo C., Riffe T., Myrskyl\u00e4 M. Years of life lost to COVID-19 in 81 countries. Sci. Rep. 2021;11:3504. doi: 10.1038/s41598-021-83040-3.", "ArticleIdList": ["10.1038/s41598-021-83040-3", "PMC7892867", "33603008"]}, {"Citation": "Islam N., Jdanov D.A., Shkolnikov V.M., Khunti K., Kawachi I., White M., Lewington S., Lacey B. Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: Time series analysis in 37 countries. BMJ. 2021;375:e066768. doi: 10.1136/bmj-2021-066768.", "ArticleIdList": ["10.1136/bmj-2021-066768", "PMC8564739", "34732390"]}, {"Citation": "Foreman K.J., Marquez N., Dolgert A., Fukutaki K., Fullman N., McGaughey M., Pletcher M.A., Smith A.E., Tang K., Yuan C.W., et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet. 2018;392:2052\u20132090. doi: 10.1016/S0140-6736(18)31694-5.", "ArticleIdList": ["10.1016/S0140-6736(18)31694-5", "PMC6227505", "30340847"]}, {"Citation": "Ilinca S., Calciolari S. The patterns of health care utilization by elderly Europeans: Frailty and its implications for health systems. Health Serv. Res. 2015;50:305\u2013320. doi: 10.1111/1475-6773.12211.", "ArticleIdList": ["10.1111/1475-6773.12211", "PMC4319884", "25139146"]}, {"Citation": "Kohn J.L., Liu J.S. The dynamics of medical care use in the British household panel survey. Health Econ. 2013;22:687\u2013710. doi: 10.1002/hec.2845.", "ArticleIdList": ["10.1002/hec.2845", "22692918"]}, {"Citation": "Mazzuco S., Campostrini S. Life expectancy drop in 2020. Estimates based on Human Mortality Database. PLoS ONE. 2022;17:e0262846. doi: 10.1371/journal.pone.0262846.", "ArticleIdList": ["10.1371/journal.pone.0262846", "PMC8803147", "35100285"]}, {"Citation": "Darmon N., Khlat M. An overview of the health status of migrants in France, in relation to their dietary practices. Public Health Nutr. 2001;4:163\u2013172. doi: 10.1079/PHN200064.", "ArticleIdList": ["10.1079/PHN200064", "11299088"]}, {"Citation": "Khlat M., Legleye S., Bricard D. Gender Patterns in Immigrants\u2019 Health Profiles in France: Tobacco, Alcohol, Obesity and Self-Reported Health. Int. J. Environ. Res. Public Health. 2020;17:8759. doi: 10.3390/ijerph17238759.", "ArticleIdList": ["10.3390/ijerph17238759", "PMC7728336", "33255730"]}, {"Citation": "Beno\u00eet C., Coron G. Private Health Insurance in France: Between Europeanization and Collectivization. Milbank Q. 2019;97:1108\u20131150. doi: 10.1111/1468-0009.12420.", "ArticleIdList": ["10.1111/1468-0009.12420", "PMC6904265", "31556171"]}, {"Citation": "Leonardi G., Colonnello V., Farinelli M., Bertoletti E., Russo P.M. One size does not fit all: Individual differences in attachment style and fear of COVID-19 in hospitalized elderly patients. Psychogeriatrics. 2021;21:848\u2013849. doi: 10.1111/psyg.12719.", "ArticleIdList": ["10.1111/psyg.12719", "PMC8447056", "34180108"]}, {"Citation": "Wastesson J.W., Martikainen J.E., Zo\u00ebga H., Schmidt M., Karlstad \u00d8., Potteg\u00e5rd A. Trends in Use of Paracetamol in the Nordic Countries. Basic Clin. Pharm. Toxicol. 2018;123:301\u2013307. doi: 10.1111/bcpt.13003.", "ArticleIdList": ["10.1111/bcpt.13003", "29527817"]}, {"Citation": "Gedeborg R., Svennblad B., Holm L., Sj\u00f6gren H., Bardage C., Personne M., Sj\u00f6berg G., Feltelius N., Zethelius B. Increased availability of paracetamol in Sweden and incidence of paracetamol poisoning: Using laboratory data to increase validity of a population-based registry study. Pharmacoepidemiol. Drug Saf. 2017;26:518\u2013527. doi: 10.1002/pds.4166.", "ArticleIdList": ["10.1002/pds.4166", "28083980"]}, {"Citation": "Hawkins L.C., Edwards J.N., Dargan P.I. Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom: A review of the literature. Drug Saf. 2007;30:465\u2013479. doi: 10.2165/00002018-200730060-00002.", "ArticleIdList": ["10.2165/00002018-200730060-00002", "17536874"]}, {"Citation": "Bateman D.N., Gorman D.R., Bain M., Inglis J.H., House F.R., Murphy D. Legislation restricting paracetamol sales and patterns of self-harm and death from paracetamol-containing preparations in Scotland. Br. J. Clin. Pharmacol. 2006;62:573\u2013581. doi: 10.1111/j.1365-2125.2006.02668.x.", "ArticleIdList": ["10.1111/j.1365-2125.2006.02668.x", "PMC1885177", "17061964"]}, {"Citation": "Morgan O.W., Griffiths C., Majeed A. Interrupted time-series analysis of regulations to reduce paracetamol (acetaminophen) poisoning. PLoS Med. 2007;4:e105. doi: 10.1371/journal.pmed.0040105.", "ArticleIdList": ["10.1371/journal.pmed.0040105", "PMC1845154", "17407385"]}, {"Citation": "Hudec R., Bo\u017eekov\u00e1 L., Tiso\u0148ov\u00e1 J. Consumption of three most widely used analgesics in six European countries. J. Clin. Pharm. Ther. 2012;37:78\u201380. doi: 10.1111/j.1365-2710.2011.01256.x.", "ArticleIdList": ["10.1111/j.1365-2710.2011.01256.x", "21466569"]}, {"Citation": "Chirumbolo S., Simonetti V., Franzini M., Valdenassi L., Bertossi D., Pandolfi S. Estimating coronavirus disease 2019 (COVID-19)-caused deaths in hospitals and healthcare units: Do hospital-acquired infections play a role? Comments with a proposal. Infect. Control. Hosp. Epidemiol. 2021;19:1\u20132. doi: 10.1017/ice.2021.122.", "ArticleIdList": ["10.1017/ice.2021.122", "PMC8047388", "33736720"]}, {"Citation": "Romanova E.S., Vasilyev V.V., Startseva G., Karev V., Rybakova M.G., Platonov P.G. Cause of death based on systematic post-mortem studies in patients with positive SARS-CoV-2 tissue PCR during the COVID-19 pandemic. J. Intern. Med. 2021;290:655\u2013665. doi: 10.1111/joim.13300.", "ArticleIdList": ["10.1111/joim.13300", "PMC8250818", "33872433"]}, {"Citation": "Grosse C., Grosse A., Salzer H.J.F., D\u00fcnser M.W., Motz R., Langer R. Analysis of cardiopulmonary findings in COVID-19 fatalities: High incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia. Cardiovasc. Pathol. 2020;49:107263. doi: 10.1016/j.carpath.2020.107263.", "ArticleIdList": ["10.1016/j.carpath.2020.107263", "PMC7365076", "32784110"]}, {"Citation": "Edler C., Schr\u00f6der A.S., Aepfelbacher M., Fitzek A., Heinemann A., Heinrich F., Klein A., Langenwalder F., L\u00fctgehetmann M., Mei\u00dfner K., et al. Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany. Int. J. Legal Med. 2020;134:1275\u20131284. doi: 10.1007/s00414-020-02317-w.", "ArticleIdList": ["10.1007/s00414-020-02317-w", "PMC7271136", "32500199"]}, {"Citation": "Sadegh Beigee F., Pourabdollah Toutkaboni M., Khalili N., Nadji S.A., Dorudinia A., Rezaei M., Askari E., Farzanegan B., Marjani M., Rafiezadeh A. Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients. Pathol. Res. Pract. 2020;216:153228. doi: 10.1016/j.prp.2020.153228.", "ArticleIdList": ["10.1016/j.prp.2020.153228", "PMC7837112", "32979740"]}, {"Citation": "Dwiputra Hernugrahanto K., Novembri Utomo D., Hariman H., Budhiparama N.C., Medika Hertanto D., Santoso D., Hogendoorn P.C.W. Thromboembolic involvement and its possible pathogenesis in COVID-19 mortality: Lesson from post-mortem reports. Eur. Rev. Med. Pharmacol. Sci. 2021;25:1670\u20131679.", "ArticleIdList": ["33629337"]}, {"Citation": "Di Luise E., Magni P.A. Interim recommendations for the management of forensic investigation during the COVID-19 pandemic: An Italian perspective. Sci. Justice. 2021;61:735\u2013742. doi: 10.1016/j.scijus.2021.08.002.", "ArticleIdList": ["10.1016/j.scijus.2021.08.002", "PMC8375245", "34802647"]}, {"Citation": "Colleluori G., Graciotti L., Pesaresi M., Di Vincenzo A., Perugini J., Di Mercurio E., Caucci S., Bagnarelli P., Zingaretti C.M., Nisoli E., et al. Visceral fat inflammation and fat embolism are associated with lung\u2019s lipidic hyaline membranes in subjects with COVID-19. Int. J. Obes. 2022;26:1\u20139. doi: 10.1038/s41366-022-01071-w.", "ArticleIdList": ["10.1038/s41366-022-01071-w", "PMC8790008", "35082385"]}, {"Citation": "Mah\u00e9 I., Caulin C., Bergmann J.F. Does paracetamol potentiate the effects of oral anticoagulants?: A literature review. Drug. Saf. 2004;27:325\u2013333.", "ArticleIdList": ["15061686"]}, {"Citation": "Mah\u00e9 I., Bertrand N., Drouet L., Simoneau G., Mazoyer E., Bal dit Sollier C., Caulin C., Bergmann J.F. Paracetamol: A haemorrhagic risk factor in patients on warfarin. Br. J. Clin. Pharmacol. 2005;59:371\u2013374. doi: 10.1111/j.1365-2125.2004.02199.x.", "ArticleIdList": ["10.1111/j.1365-2125.2004.02199.x", "PMC1884780", "15752384"]}, {"Citation": "Parra D., Beckey N.P., Stevens G.R. The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy. Pharmacotherapy. 2007;27:675\u2013683. doi: 10.1592/phco.27.5.675.", "ArticleIdList": ["10.1592/phco.27.5.675", "17461702"]}, {"Citation": "Mah\u00e9 I., Bertrand N., Drouet L., Bal Dit Sollier C., Simoneau G., Mazoyer E., Caulin C., Bergmann J.F. Interaction between paracetamol and warfarin in patients: A double-blind, placebo-controlled, randomized study. Haematologica. 2006;91:1621\u20131627.", "ArticleIdList": ["17145598"]}, {"Citation": "Pinson G.M., Beall J.W., Kyle J.A. A review of warfarin dosing with concurrent acetaminophen therapy. J. Pharm. Pract. 2013;26:518\u2013521. doi: 10.1177/0897190013488802.", "ArticleIdList": ["10.1177/0897190013488802", "23736105"]}, {"Citation": "Munsterhjelm E., Munsterhjelm N.M., Niemi T.T., Ylikorkala O., Neuvonen P.J., Rosenberg P.H. Dose-dependent inhibition of platelet function by acetaminophen in healthy volunteers. Anesthesiology. 2005;103:712\u2013717. doi: 10.1097/00000542-200510000-00009.", "ArticleIdList": ["10.1097/00000542-200510000-00009", "16192763"]}, {"Citation": "COVID-19 Autopsy The first COVID-19 autopsy in Spain performed during the early stages of the pandemic. Rev. Esp Patol. 2020;53:182\u2013187.", "ArticleIdList": ["PMC7245282", "32650969"]}, {"Citation": "Navarro Conde P., Alemany Monraval P., Medina Medina C., Jim\u00e9nez S\u00e1nchez A., Andr\u00e9s Teruel J.C., Ferrando Marco J., Puglia Santos V., Mayordomo Aranda E. Autopsy findings from the first known death from Severe Acute Respiratory Syndrome SARS-CoV-2 in Spain. Rev. Esp. Patol. 2020;53:88\u2013192. doi: 10.1016/j.patol.2020.04.002.", "ArticleIdList": ["10.1016/j.patol.2020.04.002", "PMC7211676", "32650970"]}, {"Citation": "Filograna L., Grassi S., Manenti G., Di Donna C., Tatulli D., Nardoni F., Masini V., Ausania F., Grassi V.M., Floris R., et al. Postmortem CT pulmonary findings in SARS-CoV-2-positive cases: Correlation with lung histopathological findings and autopsy results. Int. J. Leg. Med. 2022;20:1135\u20131140. doi: 10.1007/s00414-022-02793-2.", "ArticleIdList": ["10.1007/s00414-022-02793-2", "PMC8853405", "35157128"]}, {"Citation": "Grassi S., Arena V., Cattani P., Dell\u2019Aquila M., Liotti F.M., Sanguinetti M., Oliva A., GEMELLI AGAINST COVID-19 Group SARS-CoV-2 viral load and replication in postmortem examinations. Int. J. Leg. Med. 2022;24:1\u20135. doi: 10.1007/s00414-021-02753-2.", "ArticleIdList": ["10.1007/s00414-021-02753-2", "PMC8784985", "35072749"]}, {"Citation": "Wu M.A., Lopez G., Nebuloni M., Ottolina D., Montomoli J., Carsana L., Fossali T., Castelli A., Rech R., Cogliati C., et al. Lung histopathologic clusters in severe COVID-19: A link between clinical picture and tissue damage. Crit. Care. 2021;13:423. doi: 10.1186/s13054-021-03846-5.", "ArticleIdList": ["10.1186/s13054-021-03846-5", "PMC8667540", "34903264"]}, {"Citation": "Fanni D., Cerrone G., Saba L., Demontis R., Congiu T., Piras M., Gerosa C., Suri J.S., Coni P., Caddori A., et al. Thrombotic sinusoiditis and local diffuse intrasinusoidal coagulation in the liver of subjects affected by COVID-19: The evidence from histology and scanning electron microscopy. Eur. Rev. Med. Pharmacol. Sci. 2021;25:5904\u20135912.", "ArticleIdList": ["34661248"]}, {"Citation": "Congiu T., Demontis R., Cau F., Piras M., Fanni D., Gerosa C., Botta C., Scano A., Chighine A., Faedda E., et al. Scanning electron microscopy of lung disease due to COVID-19\u2013a case report and a review of the literature. Eur. Rev. Med. Pharmacol. Sci. 2021;25:7997\u20138003.", "ArticleIdList": ["34982463"]}, {"Citation": "Wang B., Yee Aw T., Stokes K.Y. N-acetylcysteine attenuates systemic platelet activation and cerebral vessel thrombosis in diabetes. Redox Biol. 2018;14:218\u2013228. doi: 10.1016/j.redox.2017.09.005.", "ArticleIdList": ["10.1016/j.redox.2017.09.005", "PMC5619994", "28961512"]}, {"Citation": "Zangrillo A., Gattinoni L. Learning from mistakes during the pandemic: The Lombardy lesson. Intensive Care Med. 2020;46:1622\u20131623. doi: 10.1007/s00134-020-06137-9.", "ArticleIdList": ["10.1007/s00134-020-06137-9", "PMC7272593", "32504102"]}, {"Citation": "Bottari C. Some reflections on organizational profiles in Italy in the time of COVID-19. Int. J. Risk Saf. Med. 2020;31:117\u2013119. doi: 10.3233/JRS-201005.", "ArticleIdList": ["10.3233/JRS-201005", "PMC7504984", "32568120"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "2", "Day": "17"}, {"Year": "2022", "Month": "3", "Day": "16"}, {"Year": "2022", "Month": "3", "Day": "30"}, {"Year": "2022", "Month": "4", "Day": "12", "Hour": "1", "Minute": "15"}, {"Year": "2022", "Month": "4", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "2"}], "PublicationStatus": "epublish", "ArticleIdList": ["35409942", "PMC8998583", "10.3390/ijerph19074262", "ijerph19074262"]}}], "PubmedBookArticle": []}